Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.

Majhail NS, Mothukuri JM, Brunstein CG, Weisdorf DJ.

Biol Blood Marrow Transplant. 2009 May;15(5):564-73. doi: 10.1016/j.bbmt.2009.01.011. Epub 2009 Mar 9.

3.
4.

The evolution of hematopoietic SCT in myelodysplastic syndrome.

Kindwall-Keller T, Isola LM.

Bone Marrow Transplant. 2009 Apr;43(8):597-609. doi: 10.1038/bmt.2009.28. Epub 2009 Mar 2. Review.

PMID:
19252532
5.

Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity.

Johnston L.

Best Pract Res Clin Haematol. 2008 Jun;21(2):177-92. doi: 10.1016/j.beha.2008.02.006. Review.

PMID:
18503985
6.

[Umbilical cord blood as a source of stem cells].

Bojanić I, Golubić Cepulić B.

Acta Med Croatica. 2006 Jun;60(3):215-25. Review. Croatian.

PMID:
16933834
7.

Unrelated umbilical cord blood transplantation in children and adults.

Koh LP.

Ann Acad Med Singapore. 2004 Sep;33(5):559-69. Review.

8.

Umbilical cord blood transplantation--how, when and for whom?

Cohen Y, Nagler A.

Blood Rev. 2004 Sep;18(3):167-79. Review.

PMID:
15183901
9.

Umbilical cord blood transplantation in adult myeloid leukemia.

Tse WW, Zang SL, Bunting KD, Laughlin MJ.

Bone Marrow Transplant. 2008 Mar;41(5):465-72. doi: 10.1038/sj.bmt.1705994. Epub 2008 Feb 4. Review.

PMID:
18246116
10.

Non-myeloablative umbilical cord blood transplantation.

Horwitz ME, Chao N.

Best Pract Res Clin Haematol. 2010 Jun;23(2):231-6. doi: 10.1016/j.beha.2010.06.001. Review.

PMID:
20837335
11.

Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.

Resnick IB, Shapira MY, Slavin S.

Transpl Immunol. 2005 Aug;14(3-4):207-19. Epub 2005 Apr 26. Review.

PMID:
15982565
12.

Reduced-intensity conditioning and umbilical cord blood transplantation in adults.

Cutler C, Ballen K.

Bone Marrow Transplant. 2009 Nov;44(10):667-71. doi: 10.1038/bmt.2009.283. Epub 2009 Oct 5. Review.

PMID:
19802028
13.

Recent advances in bone marrow transplantation in hemoglobinopathies.

Michlitsch JG, Walters MC.

Curr Mol Med. 2008 Nov;8(7):675-89. Review.

PMID:
18991653
14.

Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation.

Champlin R, Khouri I, Anderlini P, Gajewski J, Kornblau S, Molldrem J, Shimoni A, Ueno N, Giralt S.

Bone Marrow Transplant. 2001 May;27 Suppl 2:S13-22. Review.

15.

T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor.

Bashey A, Solomon SR.

Bone Marrow Transplant. 2014 Aug;49(8):999-1008. doi: 10.1038/bmt.2014.62. Epub 2014 May 19. Review.

PMID:
24842530
16.

Hematopoietic stem-cell transplantation using umbilical-cord blood.

Cohena Y, Nagler A.

Leuk Lymphoma. 2003 Aug;44(8):1287-99. Review.

PMID:
12952221
17.

Infectious complications following unrelated cord blood transplantation.

van Burik JA, Brunstein CG.

Vox Sang. 2007 May;92(4):289-96. Review.

PMID:
17456152
18.

Can reduced-intensity allogeneic transplantation cure older adults with AML?

Storb R.

Best Pract Res Clin Haematol. 2007 Mar;20(1):85-90. Review.

PMID:
17336258
19.

Stem cell transplantation (cord blood transplants).

Chao NJ, Emerson SG, Weinberg KI.

Hematology Am Soc Hematol Educ Program. 2004:354-71. Review.

PMID:
15561692
20.

New approaches for improving engraftment after cord blood transplantation.

Rocha V, Broxmeyer HE.

Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S126-32. doi: 10.1016/j.bbmt.2009.11.001. Epub 2009 Nov 5. Review.

Items per page

Supplemental Content

Write to the Help Desk